{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:29:41Z","timestamp":1792466981397,"version":"4.5.0"},"reference-count":68,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["NIEHS\/NIH 2T32ES007126-41"],"award-info":[{"award-number":["NIEHS\/NIH 2T32ES007126-41"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI166639"],"award-info":[{"award-number":["R21 AI166639"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peanut allergy is caused by aberrant IgE-driven immune responses to a well-defined set of peptide sequences within allergenic proteins. Oral and sublingual desensitization therapies are associated with the elicitation of IgG antibodies against allergenic proteins that interfere with IgE-induced effects. We tested whether inducing peptide-specific IgG responses by displaying key epitopes on immunogenic protein nanoparticle platforms protected against peanut allergy. A panel of 10 IgE epitopes from Ara h 2, the major degranulation-inducing peanut allergen, were displayed on two virus-like particles (VLPs): modified versions of both the bacteriophage PP7 coat protein and the iron-regulating encapsulin nanocompartment of the soil bacterium Myxococcus xanthus. Two peptide epitopes (Ah2-1, DPYSPSQDPYSPSPYDRRGAGSSQ, and Ah2-6, HASARQQWELQGDRRCQSQLERAN) were found to elicit strong and selective serum antibody responses against the full-length Ara h 2 protein. Immunization with a heterologous schedule (priming with PP7-displayed peptides, boosting with the corresponding encapsulin, and adjuvanting with the laboratory analogue of the clinical squalene-based adjuvant AS03) protected BALB\/cJ mice against anaphylaxis in challenges with full-length Ara h 2 and whole peanut extract. These results suggest that focusing IgG-generating immune responses against specific peptide epitopes may be an effective prophylactic strategy against food allergies for which dominant epitopes are known.<\/jats:p>","DOI":"10.1021\/acsnanomed.6c00076","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:50:04Z","timestamp":1781963404000},"page":"1987-1996","source":"Crossref","is-referenced-by-count":1,"title":["Immunization\nwith Virus-Like Particles Displaying\nAra h 2-Derived Peptides to Mitigate Peanut Allergy"],"prefix":"10.1021","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-3852","authenticated-orcid":true,"given":"Johanna M.","family":"Smeekens","sequence":"first","affiliation":[{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-3533","authenticated-orcid":true,"given":"Matthew C.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Georgia Institute of Technology , , , ,","place":["Atlanta, Georgia, United States, 30332"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahlia","family":"Carl","sequence":"additional","affiliation":[{"name":"Georgia Institute of Technology , , , ,","place":["Atlanta, Georgia, United States, 30332"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Humphrey","sequence":"additional","affiliation":[{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Turner","sequence":"additional","affiliation":[{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Krempski","sequence":"additional","affiliation":[{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6056-9958","authenticated-orcid":true,"given":"Soheila J.","family":"Maleki","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture , , , ,","place":["New Orleans, Louisiana, United States, 70124"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda R.","family":"Podilapu","sequence":"additional","affiliation":[{"name":"Georgia Institute of Technology , , , ,","place":["Atlanta, Georgia, United States, 30332"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Vickery","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-3108","authenticated-orcid":true,"given":"M. G.","family":"Finn","sequence":"additional","affiliation":[{"name":"Georgia Institute of Technology , , , ,","place":["Atlanta, Georgia, United States, 30332"]},{"name":"Georgia Institute of Technology , , , ,","place":["Atlanta, Georgia, United States, 30332"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kulis","sequence":"additional","affiliation":[{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]},{"name":"University of North Carolina , , , ,","place":["Chapel Hill, North Carolina, United States, 27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"2026090910070748300_cit1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and Severity\nof Food Allergies Among US Adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw\nOpen"},{"key":"2026090910070748300_cit2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12016-018-8680-5","article-title":"Mechanisms of Oral\nTolerance","volume":"55","author":"Tordesillas","year":"2018","journal-title":"Clin Rev. Allergy Immunol"},{"key":"2026090910070748300_cit3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaci.2017.11.005","article-title":"Mechanisms\nof food allergy","volume":"141","author":"Sampson","year":"2018","journal-title":"J.\nAllergy Clin Immunol"},{"key":"2026090910070748300_cit4","doi-asserted-by":"publisher","first-page":"1389669","DOI":"10.3389\/falgy.2024.1389669","article-title":"Allergen-specific\nIgA and IgG antibodies as inhibitors of mast cell function in food\nallergy","volume":"5","author":"Furiness","year":"2024","journal-title":"Front Allergy"},{"key":"2026090910070748300_cit5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jaci.2014.05.042","article-title":"Oral immunotherapy induces IgG antibodies that act\nthrough FcgammaRIIb to suppress IgE-mediated hypersensitivity","volume":"134","author":"Burton","year":"2014","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized Trial of\nPeanut Consumption in Infants at Risk for Peanut Allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2026090910070748300_cit7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa1514209","article-title":"Effect of Avoidance on Peanut Allergy after Early Peanut Consumption","volume":"374","author":"Du Toit","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"2026090910070748300_cit8","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300311","article-title":"Follow-up to Adolescence after Early\nPeanut Introduction for Allergy Prevention","volume":"3","author":"Du Toit","year":"2024","journal-title":"NEJM Evid"},{"key":"2026090910070748300_cit9","doi-asserted-by":"publisher","DOI":"10.1111\/all.70111","article-title":"Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual\nImmunotherapy and Are Associated With Remission in 1\u20134-Year-Old\nChildren","author":"Singh","year":"2025","journal-title":"Allergy"},{"key":"2026090910070748300_cit10","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/all.12895","article-title":"Component-resolved analysis of IgA, IgE, and IgG4 during\negg OIT identifies markers associated with sustained unresponsiveness","volume":"71","author":"Wright","year":"2016","journal-title":"Allergy"},{"issue":"448","key":"2026090910070748300_cit11","doi-asserted-by":"publisher","first-page":"455.e5","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy\nof sublingual and oral immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained\nunresponsiveness to peanut\nin subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2018.10.025","article-title":"Epicutaneous\nimmunotherapy for peanut allergy modifies IgG(4) responses to major\npeanut allergens","volume":"143","author":"Koppelman","year":"2019","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/cea.13305","article-title":"Blocking antibodies induced by peanut\noral and sublingual immunotherapy suppress basophil activation and\nare associated with sustained unresponsiveness","volume":"49","author":"Orgel","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"2026090910070748300_cit15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaci.2019.09.005","article-title":"Peanut oral immunotherapy induces\nblocking antibodies but does not change the functional characteristics\nof peanut-specific IgE","volume":"145","author":"Santos","year":"2020","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jaci.2024.02.017","article-title":"Neutralizing IgG(4)\nantibodies are a biomarker of sustained\nefficacy after peanut oral immunotherapy","volume":"153","author":"Keswani","year":"2024","journal-title":"J.\nAllergy Clin Immunol"},{"key":"2026090910070748300_cit17","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41467-018-03636-8","article-title":"Treating\ncat allergy with monoclonal\nIgG antibodies that bind allergen and prevent IgE engagement","volume":"9","author":"Orengo","year":"2018","journal-title":"Nat. Commun."},{"key":"2026090910070748300_cit18","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jaci.2024.07.014","article-title":"Preclinical\nefficacy of peanut-specific IgG4 antibody therapeutic IGNX001","volume":"154","author":"Croote","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026090910070748300_cit19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/14760584.6.3.381","article-title":"Virus-like\nparticles: flexible platforms for vaccine development","volume":"6","author":"Chackerian","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"2026090910070748300_cit20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size,\ngeometry, kinetics\nand molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol"},{"key":"2026090910070748300_cit21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI91192","article-title":"T cells control the generation of\nnanomolar-affinity anti-glycan antibodies","volume":"127","author":"Polonskaya","year":"2017","journal-title":"J.\nClin Invest"},{"key":"2026090910070748300_cit22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/vaccines6030037","article-title":"Interaction of Viral\nCapsid-Derived Virus-Like Particles (VLPs) with the Innate Immune\nSystem","volume":"6","author":"Mohsen","year":"2018","journal-title":"Vaccines"},{"key":"2026090910070748300_cit23","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1021\/acscentsci.7b00311","article-title":"Virus-like\nParticle Display of the alpha-Gal Carbohydrate for Vaccination against\nLeishmania Infection","volume":"3","author":"Moura","year":"2017","journal-title":"ACS Cent Sci."},{"key":"2026090910070748300_cit24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/cbic.200700225","article-title":"Anti-carbohydrate antibodies\nelicited by polyvalent display on a viral scaffold","volume":"8","author":"Kaltgrad","year":"2007","journal-title":"Chembiochem"},{"key":"2026090910070748300_cit25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.chembiol.2010.03.012","article-title":"Defining criteria for oligomannose\nimmunogens for HIV using icosahedral virus capsid scaffolds","volume":"17","author":"Astronomo","year":"2010","journal-title":"Chem. Biol."},{"key":"2026090910070748300_cit26","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/acsnano.4c14369","article-title":"Substructure-Specific\nAntibodies Against Fentanyl Derivatives","volume":"19","author":"Chapman","year":"2025","journal-title":"ACS\nNano"},{"key":"2026090910070748300_cit27","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2217\/nnm.14.107","article-title":"Virus-like particles as antigenic\nnanomaterials for inducing protective immune responses in the lung","volume":"9","author":"Rynda-Apple","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"2026090910070748300_cit28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2174\/1389203718666161122113041","article-title":"Engineering Virus-like Particles\nfor Antigen and Drug Delivery","volume":"19","author":"Hill","year":"2017","journal-title":"Curr. Protein\nPept Sci."},{"key":"2026090910070748300_cit29","doi-asserted-by":"publisher","first-page":"11155","DOI":"10.1021\/bi901306p","article-title":"Assembly of hybrid bacteriophage\nQbeta virus-like particles","volume":"48","author":"Brown","year":"2009","journal-title":"Biochemistry"},{"key":"2026090910070748300_cit30","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1021\/acsnano.8b09683","article-title":"Engineering the PP7 Virus Capsid\nas a Peptide Display\nPlatform","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"2026090910070748300_cit31","doi-asserted-by":"publisher","first-page":"18470","DOI":"10.1021\/acsnano.3c06178","article-title":"Exploring\nthe Landscape of the PP7 Virus-like Particle for Peptide Display","volume":"17","author":"Keshavarz-Joud","year":"2023","journal-title":"ACS Nano"},{"key":"2026090910070748300_cit32","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1021\/ja021381e","article-title":"Bioconjugation by copper(I)-catalyzed azide-alkyne\n[3 + 2] cycloaddition","volume":"125","author":"Wang","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"2026090910070748300_cit33","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1002\/anie.200905087","article-title":"Analysis and optimization\nof copper-catalyzed azide-alkyne cycloaddition for bioconjugation","volume":"48","author":"Hong","year":"2009","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"2026090910070748300_cit34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1021\/acsnano.0c03023","article-title":"Glycan-Modified\nVirus-like Particles Evoke T Helper\nType 1-like Immune Responses","volume":"15","author":"Alam","year":"2021","journal-title":"ACS Nano"},{"key":"2026090910070748300_cit35","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1021\/acsnano.4c07360","article-title":"Carbohydrate-Lectin\nInteractions Reprogram Dendritic Cells to Promote Type 1 Anti-Tumor\nImmunity","volume":"18","author":"Lensch","year":"2024","journal-title":"ACS Nano"},{"key":"2026090910070748300_cit36","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1021\/acsnano.4c00949","article-title":"Heterologous\nPrime-Boost with Immunologically\nOrthogonal Protein Nanoparticles for Peptide Immunofocusing","volume":"18","author":"Bhattacharya","year":"2024","journal-title":"ACS Nano"},{"key":"2026090910070748300_cit37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2222.2011.03934.x","article-title":"The 2S albumin allergens of Arachis\nhypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis\nand can effectively desensitize peanut-allergic mice","volume":"42","author":"Kulis","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"2026090910070748300_cit38","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1365-2222.2009.03273.x","article-title":"Effector\nactivity of peanut allergens:\na critical role for Ara h 2, Ara h 6, and their variants","volume":"39","author":"Porterfield","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"2026090910070748300_cit39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/abbi.1997.9998","article-title":"Identification\nand mutational analysis of the immunodominant IgE binding epitopes\nof the major peanut allergen Ara h 2","volume":"342","author":"Stanley","year":"1997","journal-title":"Arch.\nBiochem. Biophys."},{"key":"2026090910070748300_cit40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000070429","article-title":"Isolation and characterization of\ntwo complete Ara h 2 isoforms cDNA","volume":"131","author":"Chatel","year":"2003","journal-title":"Int. Arch\nAllergy Immunol"},{"key":"2026090910070748300_cit41","doi-asserted-by":"publisher","first-page":"e164501","DOI":"10.1172\/JCI164501","article-title":"Immunotherapy-induced neutralizing\nantibodies disrupt allergen binding and sustain allergen tolerance\nin peanut allergy","volume":"133","author":"LaHood","year":"2023","journal-title":"J. Clin Invest"},{"key":"2026090910070748300_cit42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.alit.2025.05.007","article-title":"Convergent\nmonoclonal IgE antibodies\nfrom peanut allergic patients are multispecific to immunodominant\nepitopes of unrelated major peanut and tree nut allergens","volume":"74","author":"Kabasser","year":"2025","journal-title":"Allergol Int."},{"key":"2026090910070748300_cit43","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaci.2007.11.039","article-title":"Peanut\nepitopes for IgE and IgG4 in peanut-sensitized children in relation\nto severity of peanut allergy","volume":"121","author":"Flinterman","year":"2008","journal-title":"J. Allergy Clin\nImmunol"},{"key":"2026090910070748300_cit44","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jaci.2019.12.007","article-title":"Vaccine\nagainst peanut allergy based on engineered virus-like particles displaying\nsingle major peanut allergens","volume":"145","author":"Storni","year":"2020","journal-title":"J. Allergy Clin\nImmunol"},{"key":"2026090910070748300_cit45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaci.2024.08.010","article-title":"Ara h 2-expressing\ncucumber mosaic virus-like particle (VLP Peanut) induces in vitro\ntolerogenic cellular responses in peanut-allergic individuals","volume":"155","author":"Layhadi","year":"2025","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/mnfr.200500272","article-title":"Requirements\nfor effective IgE cross-linking on mast cells and basophils","volume":"50","author":"Knol","year":"2006","journal-title":"Mol. Nutr Food Res."},{"key":"2026090910070748300_cit47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1067\/mai.2000.107395","article-title":"A murine model of peanut anaphylaxis: T- and B-cell\nresponses to a major peanut allergen mimic human responses","volume":"106","author":"Li","year":"2000","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit48","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202506285","article-title":"Pleomorphism\nin wild-type and engineered PP7 virus-like particles","volume":"21","author":"Keshavarz-Joud","year":"2025","journal-title":"Small"},{"key":"2026090910070748300_cit49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaci.2025.03.032","article-title":"Fine resolution\nof the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants\nwith enhanced IgE binding","volume":"156","author":"Bernstein","year":"2025","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit50","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jaci.2023.08.035","article-title":"Widespread monoclonal\nIgE antibody\nconvergence to an immunodominant, proanaphylactic Ara h 2 epitope\nin peanut allergy","volume":"153","author":"Croote","year":"2024","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit51","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jaci.2024.12.1094","article-title":"Antigenic determinants underlying\nIgE-mediated anaphylaxis\nto peanut","volume":"155","author":"Smith","year":"2025","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit52","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.jaci.2024.12.1095","article-title":"Structural\ndeterminants of peanut-induced anaphylaxis","volume":"155","author":"Smith","year":"2025","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/cea.12407","article-title":"Epitope analysis\nof Ara h 2 and Ara h 6: characteristic\npatterns of IgE-binding fingerprints among individuals with similar\nclinical histories","volume":"45","author":"Otsu","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"2026090910070748300_cit54","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3389\/fimmu.2019.00736","article-title":"RNA and Toll-Like\nReceptor 7 License the Generation\nof Superior Secondary Plasma Cells at Multiple Levels in a B Cell\nIntrinsic Fashion","volume":"10","author":"Krueger","year":"2019","journal-title":"Front. Immunol."},{"key":"2026090910070748300_cit55","doi-asserted-by":"publisher","first-page":"827256","DOI":"10.3389\/fimmu.2021.827256","article-title":"TLR7 Signaling\nShapes and Maintains\nAntibody Diversity Upon Virus-Like Particle Immunization","volume":"12","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"key":"2026090910070748300_cit56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-7896-0_4","article-title":"A Mouse Model of Peanut Allergy Induced by Sensitization Through\nthe Gastrointestinal Tract","volume":"1799","author":"Orgel","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"2026090910070748300_cit57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1398-9995.2006.01012.x","article-title":"Role of\nTLR4 in allergic sensitization to food proteins in mice","volume":"61","author":"Berin","year":"2006","journal-title":"Allergy"},{"key":"2026090910070748300_cit58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/vaccines12050531","article-title":"Differential\nRegulation of DC Function, Adaptive Immunity, and MyD88 Dependence\nby MF59 and AS03-like Adjuvants","volume":"12","author":"Nakkala","year":"2024","journal-title":"Vaccines"},{"key":"2026090910070748300_cit59","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaci.2007.07.033","article-title":"Anaphylaxis:\nlessons from mouse models","volume":"120","author":"Finkelman","year":"2007","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit60","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1172\/JCI25575","article-title":"IgG-blocking\nantibodies inhibit IgE-mediated\nanaphylaxis in vivo through both antigen interception and Fc gamma\nRIIb cross-linking","volume":"116","author":"Strait","year":"2006","journal-title":"J. Clin Invest"},{"key":"2026090910070748300_cit61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.iac.2019.09.006","article-title":"Evolution of Immune\nResponses in Food Immunotherapy","volume":"40","author":"Smeekens","year":"2020","journal-title":"Immunol Allergy\nClin North Am."},{"key":"2026090910070748300_cit62","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jaci.2023.01.036","article-title":"Open-label study\nof the efficacy, safety, and durability of peanut sublingual immunotherapy\nin peanut-allergic children","volume":"151","author":"Kim","year":"2023","journal-title":"J. Allergy Clin\nImmunol"},{"key":"2026090910070748300_cit63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, Safety, and Quality of Life in a Multicenter, Randomized,\nPlacebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in\nChildren with Peanut Allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J. Allergy Clin\nImmunol Pract"},{"key":"2026090910070748300_cit64","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jaci.2017.01.018","article-title":"Lifelong memory responses\nperpetuate humoral TH2 immunity and anaphylaxis in food allergy","volume":"140","author":"Jime\u0301nez-Saiz","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026090910070748300_cit65","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jaci.2024.07.014","article-title":"Preclinical\nefficacy of peanut-specific IgG4 antibody therapeutic IGNX001","volume":"154","author":"Croote","year":"2024","journal-title":"J. Allergy Clin Immunol"},{"key":"2026090910070748300_cit66","doi-asserted-by":"publisher","first-page":"58285","DOI":"10.3791\/58285","article-title":"Antigenic Liposomes\nfor Generation of Disease-specific Antibodies","author":"Bednar","year":"2018","journal-title":"J. Vis Exp"},{"key":"2026090910070748300_cit67","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1365-2222.1998.00301.x","article-title":"Identification and partial characterization\nof multiple major allergens in peanut proteins","volume":"28","author":"de Jong","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"2026090910070748300_cit68","doi-asserted-by":"publisher","first-page":"882","DOI":"10.4049\/jimmunol.169.2.882","article-title":"Protein structure\nplays a critical role in peanut allergen\nstability and may determine immunodominant IgE-binding epitopes","volume":"169","author":"Sen","year":"2002","journal-title":"J. Immunol"}],"container-title":["ACS Nano Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnanomed.6c00076","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/anmafm\/article-pdf\/1\/8\/1987\/65182493\/acsnanomed.6c00076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/anmafm\/article-pdf\/1\/8\/1987\/65182493\/acsnanomed.6c00076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:28:17Z","timestamp":1788967697000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/anmafm\/article\/1\/8\/1987\/5165433\/Immunization-with-Virus-Like-Particles-Displaying"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,20]]},"published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnanomed.6c00076","relation":{},"ISSN":["3067-5928"],"issn-type":[{"value":"3067-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}